Recro Pharma Reports Positive Top-Line Results for Phase II Clinical Trial of IV Meloxicam
Jan 06, 2016 12:00 pm UTC| Business
IV Meloxicam Well Tolerated with Statistically Significant Analgesic Effect Reported Company on Track to Initiate Pivotal Phase III in 1Q 2016 MALVERN, Pa., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Recro Pharma, Inc....
Mitek to Present at the Needham Growth Conference in New York on January 13, 2016
Jan 06, 2016 12:00 pm UTC| Business
SAN DIEGO, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Mitek (NASDAQ:MITK) (www.miteksystems.com), a global leader in mobile capture and identity verification software solutions, today announced that it will present at the Needham...
Jan 06, 2016 12:00 pm UTC| Business
BOSTON, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) announced today that it projects its ongoing pivotal Phase 3 clinical trial evaluating omadacycline for the treatment of Acute...
Apricus Biosciences Announces Year-End 2015 Update and 2016 Growth Strategy
Jan 06, 2016 12:00 pm UTC| Business
SAN DIEGO, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today reviewed its 2015 corporate progress and...
Vectrus Earns Position in Top 100 Military Friendly® Employers List
Jan 06, 2016 12:00 pm UTC| Business
RESTON, Va., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Vectrus, Inc. (NYSE:VEC) recently earned the 2016 Military Friendly® Employer designation by Victory Media, publisher of G.I. Jobs® and Military Spouse. “As a government...
Jan 06, 2016 12:00 pm UTC| Business
SAN DIEGO, Jan. 06, 2016 (GLOBE NEWSWIRE) -- BioNano Genomics, Inc., the leader in physical genome mapping, today announced results from a study demonstrating proof of concept methodologies for CRISPR DNA labeling in...
Jan 06, 2016 12:00 pm UTC| Business
Developing a disruptive therapeutics platform targeting large unmet medical needs;First-in-class proprietary polyamine compound designed specifically for pancreatic disease;Anticipates Entering the Clinic in US during the...